BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 08/26/24
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug TargetsGlobeNewsWire • 07/25/24
Join BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12GlobeNewsWire • 05/29/24
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric DisordersGlobeNewsWire • 05/16/24
BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVAccesswire • 04/26/24
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber InstituteGlobeNewsWire • 03/08/24
BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common StockGlobeNewsWire • 02/21/24
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChipGlobeNewsWire • 02/09/24
WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public OfferingPRNewsWire • 02/05/24
WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public OfferingPRNewsWire • 02/01/24
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah WalaGlobeNewsWire • 01/26/24
BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression DataGlobeNewsWire • 01/17/24
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating CancerGlobeNewsWire • 01/16/24